This paper considers the confirmation of diagnosis, made initially fro
m histological analysis of tumour tissue, of neuroendocrine tumour dis
ease, using elevated secretory products in the blood. These include ho
rmones, peptides, neurotransmitters and packaging proteins of secretor
y vesicles such as chromogranin A.